Bezmialem Vakif University, Department of Physiotheraphy and Rehabilitation
Istanbul, Turkey (Türkiye)
NCT Number: NCT04039334
COPD is a common, preventable and treatable disease associated with an increased chronic inflammatory response of the airways and lungs to harmful gases and particles and characterized by progressive airflow restriction, which is usually progressive. Exercise intolerance is one of the most important outcomes of COPD. Dyspnea and leg fatigue are the main symptoms that limit exercise and patients restrict their activity to avoid these disturbing conditions. Exercise training is the most appropriate method for improving exercise tolerance and muscle function. It is considered and recommended by ERS and ATS as an essential component of PR. Endurance training is considered to be one of the most important components of the PR program. Walking, running, cycling, stair climbing, dancing are examples of endurance exercises. Dance-based exercise training; It is an entertaining method that increases physical, functional, cognitive, emotional and social integration. This alternative method has frequently been tried in the literature in the treatment of Parkinson's, cancer and psychiatric diseases and its effects on functional capacity, balance, and quality of life have been demonstrated. The importance of our research; This is the first study to apply dance based exercise training in chronic respiratory diseases.
The aim of this study was to investigate the effect of creative dance based exercise training on respiratory, balance and cognitive functions, respiratory and peripheral muscle strength and functional capacity in COPD patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Istanbul, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Conventional chest physiotherapy programme will include diaphragmatic breathing exercise, thoracic expansion exercises, incentive spirometer exercise (Triflo), teaching of respiratory control, relaxing and coughing techniques.
Creative dance based exercise training will be given under the supervision of a physiotherapist who takes creative dance instructor training 2 days and 60 minutes per week.
Time frame: Eight weeks
Change from baseline forced vital capacity (FVC) at 8 weeks.
Time frame: Eight weeks
Change from baseline forced forced expiratory volume in 1 second at 8 weeks.
Time frame: Eight weeks
Change from baseline peak expiratory flow (PEF) at 8 weeks.
Time frame: Eight weeks
Change from baseline CAT score at 8 weeks.
Time frame: Eight weeks
Change from baseline BODE score at 8 weeks.
Time frame: Eight weeks
Change from baseline postural stability test score in BIODEX Balance System at 8 weeks.
Time frame: Eight weeks
Change from baseline limits of stability test score in BIODEX Balance System at 8 weeks.
Time frame: Eight weeks
Change from baseline maximum inspiratory pressure at 8 weeks.
Time frame: Eight weeks
Change from baseline maximum expiratory pressure at 8 weeks.
Time frame: Eight weeks
Change from baseline distance covered in six minute walk test at 8 weeks.
Time frame: Eight weeks
Change from baseline m. quadriceps strength at 8 weeks.
Time frame: Eight weeks
Change from baseline m. biceps strength at 8 weeks.
Time frame: Eight weeks
Change from baseline handgrip strength at 8 weeks.
Bezmialem Vakif University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details